These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 32917216

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study.
    Shi H, Zhang Q, Han C, Zhen D, Lin R.
    BMC Endocr Disord; 2018 Jul 28; 18(1):51. PubMed ID: 30055596
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M, Zhao P, Shi X, Zhao A, Zhang L, Zhou L.
    BMC Endocr Disord; 2017 Jul 13; 17(1):39. PubMed ID: 28705205
    [Abstract] [Full Text] [Related]

  • 4. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B, Carmona-Bayonas A, Jimenez-Fonseca P, Capdevila J, Castaño-Pascual Á, Benavent M, Pi Barrio JJ, Teule A, Alonso V, Custodio A, Marazuela M, Segura Á, Beguiristain A, Llanos M, Martinez Del Prado MP, Diaz-Perez JA, Castellano D, Sevilla I, Lopez C, Alonso T, Garcia-Carbonero R.
    Oncologist; 2018 Apr 13; 23(4):422-432. PubMed ID: 29330208
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C, Wang W, Zhang Y, Feng X, Sun J, Zeng Y, Chen Y, Li Y, Chen M, Zhou Z, Chen J.
    Chin J Cancer; 2017 Jun 21; 36(1):51. PubMed ID: 28637502
    [Abstract] [Full Text] [Related]

  • 7. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
    Li Y, Wang YF, Tan BB, Er LM, Zhao Q, Fan LQ, Zhang ZD, Liu Y.
    Zhonghua Zhong Liu Za Zhi; 2020 May 23; 42(5):426-431. PubMed ID: 32482035
    [Abstract] [Full Text] [Related]

  • 8. Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution.
    Massironi S, Rossi RE, Casazza G, Conte D, Ciafardini C, Galeazzi M, Peracchi M.
    Neuroendocrinology; 2014 May 23; 100(2-3):240-9. PubMed ID: 25428270
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M, Čačev T, Catela Ivković T, Marout J, Ulamec M, Zjačić-Rotkvić V, Kapitanović S.
    Mol Cell Endocrinol; 2016 Apr 15; 425():61-8. PubMed ID: 26805636
    [Abstract] [Full Text] [Related]

  • 11. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.
    Foltyn W, Zajęcki W, Marek B, Kajdaniuk D, Siemińska L, Zemczak A, Kos-Kudła B.
    Endokrynol Pol; 2012 Apr 15; 63(5):362-6. PubMed ID: 23115069
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine tumors: analysis from a single-institution.
    Zeng YJ, Liu L, Wu H, Lai W, Cao JZ, Xu HY, Wang J, Chu ZH.
    Asian Pac J Cancer Prev; 2013 Apr 15; 14(10):5775-81. PubMed ID: 24289577
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Correlation Between [68Ga]DOTATATE PET/CT and Cell Proliferation in Patients With GEP-NENs.
    Yu J, Li N, Li J, Lu M, Leal JP, Tan H, Su H, Fan Y, Zhang Y, Zhao W, Zhu H, Pomper MG, Zhou Y, Yang Z.
    Mol Imaging Biol; 2019 Oct 15; 21(5):984-990. PubMed ID: 30796708
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm.
    Wang Y, Chen Y, Li X, Hu W, Zhang Y, Chen L, Chen M, Chen J.
    BMC Cancer; 2018 Jun 26; 18(1):691. PubMed ID: 29940892
    [Abstract] [Full Text] [Related]

  • 19. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
    Yao W, Wang W, Li G.
    Zhonghua Zhong Liu Za Zhi; 2014 Apr 26; 36(4):287-93. PubMed ID: 24989916
    [Abstract] [Full Text] [Related]

  • 20. Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study.
    Zhang X, Ma L, Bao H, Zhang J, Wang Z, Gong P.
    BMC Endocr Disord; 2014 Jul 08; 14():54. PubMed ID: 25001493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.